IRVING, Texas and NEW YORK, May 12,
2021 /PRNewswire/ -- Inform Diagnostics, a leading U.S.
anatomic pathology provider, and Paige, a global leader in AI-based cancer
diagnostic software for digital pathology, today announced an
agreement to accelerate the use and optimization of digital
pathology workflows at Inform Diagnostics.
Inform Diagnostics plans to immediately begin the implementation
of the FullFocus™ digital pathology viewer.
FullFocus™ will integrate into the Inform Diagnostics
subspecialty anatomic pathology workflows and laboratory
information system (LIS). The integrated solution will allow for
more streamlined logistics, faster turnaround times for pathology
results, and more efficient support of internal and external
laboratory service models.
The FDA-cleared and CE-marked Paige Platform features
FullFocus™, an intuitive and responsive viewer for
digital pathology slides, and a Data Management solution to store
digital pathology slides. The Paige digital pathology solution is designed
to be compatible with existing laboratory technology, including
most scanners, monitors, and laboratory information systems.
"The capabilities of Paige,
coupled with the medical expertise of the Inform Diagnostics
pathology team, represent a great opportunity to demonstrate the
benefits of digital pathology adoption for each of our
organizations as well as the physician clients we serve and their
patients," said Darryl Goss, Inform
Diagnostics Chief Executive Officer. "We believe the Paige Platform
will enhance the quality of patient diagnoses and significantly
improve workflow efficiency across our organization."
"We are excited to begin this collaboration with Inform
Diagnostics and its pathology experts, which enables us to
demonstrate the potential of the Paige Platform to address the
unique scale, quality, and throughput needs of a large commercial
operation," said Leo Grady, Ph.D.,
Chief Executive Officer of Paige.
"The collaboration with Inform Diagnostics comes at a pivotal time
for Paige as we accelerate our
global commercialization efforts."
About Inform Diagnostics
Inform Diagnostics is one of
the largest independent anatomic pathology laboratory businesses in
the U.S. With exceptional quality and experience, Inform
Diagnostics provides subspecialty pathologist–to–physician
interaction with timely, definitive patient diagnoses in
gastrointestinal pathology, dermatopathology, hematopathology,
neuropathology, breast pathology, molecular diagnostics (Covid-19
Testing), and genitourinary pathology. Inform Diagnostics is
profoundly impacting patient care, one diagnosis at a time, by
practicing medicine at the intersection of quality, service, and
solutions. The company is headquartered in Irving, Texas, with additional
state–of–the–art laboratories in Boston, New York
City, and Phoenix. Visit us
Paige was founded in 2017 by Thomas Fuchs, Dr.Sc. and colleagues from
Memorial Sloan Kettering Cancer Center (MSK). The company builds
computational pathology products designed so patients and their
care teams can make effective, more informed treatment decisions.
With this new class of AI-based technologies positioned to drive
the future of diagnostics, Paige
created a platform to deliver this novel technology to pathologists
to transform their workflow and increase diagnostic confidence and
productivity. Paige's products
deliver insights to pathologists and oncologists so they can arrive
efficiently at more precise diagnoses for patients. Paige is the first company to receive FDA
breakthrough designation for computational pathology products. For
additional information, please visit www.Paige.ai.
SOURCE Inform Diagnostics